Pharmabiz

CDE of NMPA grants priority review status to Leads Biolabs’ PD-L1/4-1BB bispecific antibody, opamtistomig to treat advanced EP-NEC

CDE of NMPA grants priority review status to Leads Biolabs’ PD-L1/4-1BB bispecific antibody, opamtistomig to treat advanced EP-NEC: Nanjing, China Monday, July 13, 2026, 16:00 H ...
Pharmabiz

Rani Therapeutics enters R&D collaboration with PegBio to expand obesity pipeline across multiple novel candidates

Rani Therapeutics enters R&D collaboration with PegBio to expand obesity pipeline across multiple novel candidates: San Jose, California Monday, July 13, 2026, 14:00 Hrs [IST] Ran ...
Pharmabiz

Intuitive signs MoU with Fortis Hospital to establish India’s first Total Programme Observation site in a non-metro city

Intuitive signs MoU with Fortis Hospital to establish India’s first Total Programme Observation site in a non-metro city: Our Bureau, Bengaluru Monday, July 13, 2026, 14:25 Hrs ...
Pharmabiz

Mankind Pharma to divest stake in Broadway Hospitality

The board of directors of the Mankind Pharma Limited at its meeting has considered and approved the proposal for divestment of 100% stake held in Broadway Hospitality Services Private Limited ...
Pharmabiz

China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance

China NMPA conducts management review of QMS for regulation of vaccine and drug GMP compliance: Beijing Monday, July 13, 2026, 15:00 Hrs [IST] The National Medical Products Admini ...
Pharmabiz

Aurobindo Pharma arm incorporates subsidiary in Indonesia

Aurobindo Pharma announced that PT Aurogen Pharma Indonesia, a wholly owned stepdown subsidiary of the company, has incorporated a new wholly owned subsidiary company by the name of PT Auro Pharm ...
Pharmabiz

Sanofi’s subcutaneous Sarclisa Escena approved in US

Sanofi announced that US Food and Drug Administration (FDA) has approved subcutaneous (SC) Sarclisa (isatuximab-irfc) Escena in combination with standard-of-care regimens for the treatment of patients ...
Pharmabiz

Sciverse opens new headquarters and Global Research Centre in Pune to develop diagnostic platforms

Sciverse opens new headquarters and Global Research Centre in Pune to develop diagnostic platforms: Our Bureau, Bengaluru Monday, July 13, 2026, 14:35 Hrs [IST] Sciverse Solutions ...
Pharmabiz

Health ministry launches monthly webinar series on Best Practices under NHM to promote innovation

Health ministry launches monthly webinar series on Best Practices under NHM to promote innovation: Our Bureau, Mumbai Monday, July 13, 2026, 13:40 Hrs [IST] Reinforcing its commit ...
Pharmabiz

LVPEI redesignated WHO collaborating Centre for the prevention of blindness

LVPEI redesignated WHO collaborating Centre for the prevention of blindness: Our Bureau, Bengaluru Monday, July 13, 2026, 14:15 Hrs [IST] L V Prasad Eye Institute (LVPEI) has been ...
Pharmabiz

FPME invites experts to develop ICP and IVP frameworks for merchant exporters

FPME invites experts to develop ICP and IVP frameworks for merchant exporters: Shardul Nautiyal, Mumbai Monday, July 13, 2026 ...
Pharmabiz

US FDA approves Pfizer & Astellas’ Padcev plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility

US FDA approves Pfizer & Astellas’ Padcev plus Keytruda as neoadjuvant and adjuvant treatment for MIBC regardless of cisplatin eligibility: New York Monday, July 13, 2026, 13:00 ...